Metolazone-d7
(Synonyms: SR-720-22-d7) 目录号 : GC49194An internal standard for the quantification of metolazone
Cas No.:2714484-71-4
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Metolazone-d7 is intended for use as an internal standard for the quantification of metolazone by GC- or LC-MS. Metolazone is a thiazide-like diuretic.1,2 It inhibits the Na+/Cl- cotransporter (IC50 = 0.3 µM for the rat transporter) and human carbonic anhydrase VII (CAVII), CAXII, and CAXIII (Kis = 2.1, 5.4, and 15 nM, respectively). Metolazone (0.3 and 1 mg/kg) induces fluid loss and enhances captopril-induced decreases in blood pressure in spontaneously hypertensive rats.3 Formulations containing metolazone have been used in the treatment of high blood pressure.
1.Moreno, E., CristÓbal, P.S., Rivera, M., et al.Affinity-defining domains in the Na-Cl cotransporter: A different location for C- and thiazide bindingJ. Biol. Chem.281(25)17266-17275(2006) 2.Temperini, C., Cecchi, A., Scozzafava, A., et al.Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-ray crystallographic studies for the indapamide-isozyme II adductBioorg. Med. Chem. Lett.18(8)2567-2573(2008) 3.Chiu, P.J.S., Vemulapalli, S., and Barnett, A.Acute blood pressure and urinary responses to single dose combinations of captopril and diuretics in conscious spontaneously hypertensive ratsJ. Pharm. Pharmacol.37(2)105-109(1985)
Cas No. | 2714484-71-4 | SDF | |
别名 | SR-720-22-d7 | ||
Canonical SMILES | O=C1C2=C(C=C(Cl)C(S(N)(=O)=O)=C2)NC(C)N1C3=C([2H])C([2H])=C([2H])C([2H])=C3C([2H])([2H])[2H] | ||
分子式 | C16H9D7ClN3O3S | 分子量 | 372.9 |
溶解度 | DMSO : ≥ 100 mg/mL (268.18 mM); H2O : 0.67 mg/mL (1.80 mM; Need ultrasonic) | 储存条件 | -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.6817 mL | 13.4084 mL | 26.8168 mL |
5 mM | 0.5363 mL | 2.6817 mL | 5.3634 mL |
10 mM | 0.2682 mL | 1.3408 mL | 2.6817 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。